Novel virus reduction method based on detergents and shearing forces
WO2006027111A1
Modified coagulation factor viii with enhanced stability
DE102005038012A1
Reduction of infectiousness of viruses in production of biologicals, e.g. blood or blood product, uses chemical and/or physical pretreatment, e.g. with detergent, and mechanical shear, e.g. filtration
DE102005037824A1
Reduction of virus infection in a biological process comprises using chemical and/or physical methods that possess no or only minimal virus inactivation capacity and exposing the pre-treated process to shearing stress to clear inactivation
EP1728798A1
Coagulation factor X polypeptides with modified activation properties
DE102005005824A1
Method for differentiating factor XIII versus fibrinogen-deficient states using thrombelastographic techniques
DE102004052339A1
Method for producing a stacking aid for box-shaped containers
WO2005040213A1
MODIFIED cDNA FOR HIGH EXPRESSION LEVELS OF FACTOR VIII AND ITS DERIVATIVES
CA2535984A1
C1-inh as a drug for treating viruses pathogenic to humans
DE102004037805B3
Process for the heat treatment of fibrinogen-containing pharmaceutical preparations
WO2005012354A1
Method for extending the half-life of fviii
EP1609485A1
Method for the inactivation of viral components of protein-containing biological compositions
EP1598367A1
Modified coagulation factors with enhanced stability and their derivatives
EP1593388A1
Therapeutic plasma protein-concentrates containing von willebrand factor as high molecular weight multimers
DE102004017295A1
Compounds which cause or prevent the removal of receptors from cell membranes, and methods for their detection
DE102004016065B3
Bone substitute material comprises a porous material impregnated with a solution containing factor XIII
AU2004201135A1
Use of a fibrin adhesive for tissue regeneration
DE102004009400A1
Fibrinogen purification
EP1566183A1
Use of factor XIII for stimulating the perfusion of ischemic tissue
EP1544212A1
Modified antiviral proteins with an increased negative charge
